Reckitt Benckiser Group (OTCMKTS:RBGLY - Get Free Report) was upgraded by analysts at Kepler Capital Markets from a "hold" rating to a "strong-buy" rating in a research note issued to investors on Friday,Zacks.com reports.
Other research analysts have also issued research reports about the stock. Morgan Stanley upgraded shares of Reckitt Benckiser Group from an "equal weight" rating to an "overweight" rating in a research report on Monday, March 16th. Zacks Research lowered shares of Reckitt Benckiser Group from a "hold" rating to a "strong sell" rating in a research report on Tuesday, April 7th. Jefferies Financial Group restated a "hold" rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Citigroup started coverage on shares of Reckitt Benckiser Group in a research report on Wednesday, January 14th. They issued a "buy" rating on the stock. Finally, Royal Bank Of Canada lowered shares of Reckitt Benckiser Group from an "outperform" rating to a "sector perform" rating in a research report on Wednesday, January 14th. Three research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy".
Check Out Our Latest Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Performance
Reckitt Benckiser Group stock opened at $14.16 on Friday. The company has a debt-to-equity ratio of 0.98, a quick ratio of 0.63 and a current ratio of 0.85. Reckitt Benckiser Group has a 1 year low of $12.73 and a 1 year high of $17.80. The firm's 50 day moving average price is $15.24 and its two-hundred day moving average price is $15.69.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.